AC Immune Corp (ACIU): Earnings per share for the last twelve months

Graphic logo of AC Immune Inc (ACIU)

AC Immune relies on strategic partnerships with pharma giants to fund its testing. High profitability is sustained by a streamlined international cold chain for component supply. Net income per share over the last four quarters on this GURU.Markets platform chart shows that the indicator level is -0.52. The issuer's financial success is currently based entirely on grants and the results of clinical trials for Alzheimer's disease.

ACIU acimmune.com Net earnings per share for the last 12 months (07/04/2022 - 11/12/2026)

Financial and market metric breakdowns for AC Immune S.A. (ACIU)

- stock price and consensus target price:
Stock Price AC Immune|ACIU - Analyst Median Target
- stock exchange capitalization data:
Market Value AC Immune SA|ACIU - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Net Assets per Single Share AC Immune|ACIU - Company Net Assets|Market Cap to Net Assets Ratio acimmune.com|ACIU - Company Total Assets
- debt and liquidity data:
Debt to Equity AC Immune|ACIU - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital AC Immune Corp|ACIU - Company Cumulative Debt|Debts to Book Capitalization AC Immune SA|ACIU - Company Long-Term Debts|Company Short-Term Debts AC Immune|Quick Ratio acimmune.com
- earnings and multiples data:
ACIU - Net Financial Result|Future Profit AC Immune|ACIU - P/E Multiple|Future Price to Earnings AC Immune SA|ACIU - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple AC Immune SA|ACIU - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months AC Immune|ACIU - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months acimmune.com|ACIU - Earnings per share increase in current year|Net earnings per share growth forecast for next year AC Immune
Basic company analysis:AC Immune (ACIU)
Mass-produced product of AC Immune S.A.

The efficiency of logistics chains for delivering molecules to clinics directly impacts the operating expenses of AC Immune (ACIU), which is reflected in the final net earnings per share. By analyzing the earnings per share slice over the last 12 months, an investor assesses the real business yield over a rolling period, where any sharp deviations in the curve signal a risk of overpaying for the asset.

Competitors of AC Immune (ACIU)

Biogen Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters neurocrine.com NBIX|Regencell Bioscience Holdings Limited (RGC) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Axsome|Earnings per share for the last twelve months ACADIA Pharmaceuticals Inc|Net earnings per share for the last 12 months Xenon Corp (XENE)|Net earnings per share for the last 12 months VKTX (Viking Therapeutics)|Net earnings per share (EPS TTM) supernus.com (SUPN)|Earnings per share for the last twelve months Catalyst Pharmaceuticals, Inc. CPRX|DNLI: Earnings per share for the last 12 months|Harmony Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Biohaven Corp|AMLX: Net earnings per share (EPS TTM)|trevitherapeutics.com (TRVI) - Net earnings per share (EPS TTM)|PRAX (Praxis Precision Medicines, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Anavex (AVXL)|Net earnings per share (EPS TTM) CBLL|Net earnings per share for the last four quarters Prothena Biosciences|Alector - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) annexonbio.com ANNX|OMER - Earnings per share for the last twelve months|NGNE (Neurogene Inc) - Earnings per share for the last 12 months|VYGR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neumora Corp (NMRA)|Net earnings per share for the last 12 months SCLX|Net earnings per share (EPS TTM) tevogen.com|Earnings per share for the last twelve months Alpha Cognition (ACOG)|CGTX (Cognition Therapeutics Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Inhibikase IKT|Cassava Pharma (SAVA) - Net earnings per one share for the last twelve months|Assertio Therapeutics - Net earnings per share (EPS TTM)|COYA - Net earnings per share (EPS TTM)|VTGN: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Ovid Therapeutics|Net earnings per share for the last 12 months ABOS|CRVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATHE|Net earnings per share for the last four quarters clene.com|Earnings per share for the last twelve months PepGen PEPG|JUNS - Net earnings per share for the last 12 months|RLMD - Earnings per share for the last twelve months|Annovis Bio Corporation (ANVS) - Net earnings per share for the last 12 months|GRCE (gracetx.com) - Net earnings per share for the last 12 months|fireflyneuro.com (AIFF) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ANEW Medical|Earnings per share for the last 12 months NRSN (NeuroSense Therapeutics, Ltd.)|Net earnings per share (EPS TTM) RVPH|MTVA - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) NRXS (NeurAxis, Inc.)|Net earnings per share (EPS TTM) Helius Medical Technologies, Inc. HSDT|Passage Bio Corp - Net earnings per share (EPS TTM)|Neuphoria Therapeutics Inc. (NEUP) - Net earnings per share for the last 12 months|NERV: Net earnings per share (EPS TTM)|ATHA - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ADXN|Net earnings per share (EPS TTM) Alzamend|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|protagenic.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Net earnings per one share for the last twelve months|ATXI: Net earnings per share for the last 12 months|BCLI - Net earnings per share (EPS TTM)|Cara Therapeutics (CARA) - Earnings per share for the last twelve months|Chromocell Therapeutics Corp - Earnings per share for the trailing year|Earnings per share for the last twelve months Eliem Therapeutics, Inc.|Net earnings per one share for the last twelve months Intra-Cellular ITCI|Net earnings per share (EPS TTM) LBPH|Net earnings per share (EPS TTM) marinuspharma.com (MRNS)|Net earnings per share (EPS TTM) NKGN (NKGen Biotech)|NRBO - Net earnings per share for the last 12 months|SAGE: Net earnings per share for the last 12 months|Earnings per share for the trailing year SNPX (Synaptogenix, Inc)|TRVN: Net earnings per share (EPS TTM)|VIGL - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Anew Medical|Net earnings per share for the last 12 months Cerevel Therapeutics Inc (CERE)